Expert review: Physiology-guided management of MVD in ACS patients Expert review: Physiology-guided management of MVD in ACS patients
Original research: Lipid-lowering protocol and clinical outcomes Original research: Lipid-lowering protocol and clinical outcomes
Original research: BioMime SES in obstructive CAD Original research: BioMime SES in obstructive CAD
Editorial: Less metal – the latest evolution in PCI Editorial: Less metal – the latest evolution in PCI
Original research: Impact of ACS on neoatherosclerosis Original research: Impact of ACS on neoatherosclerosis

About the journal

AsiaIntervention is the official journal of the Asian-Pacific Society of Interventional Cardiology (APSIC) and the Interventional Cardiology Foundation of India (ICFI).
It is an international, English language, peer-reviewed journal whose aim is to create a forum of high quality research and education in the field of percutaneous and surgical cardiovascular interventions.
It is released twice a year, in paper and electronic formats.
AsiaIntervention has applied for indexation in Science Citation Index® (ISI), SciVerse Scopus, MEDLINE®/PubMed®.
Subscribe newsletter

Volume 10, Number 3, October 2024

AsiaIntervention - New Issue October 2024

 

This issue of AsiaIntervention features a review on interventional treatment for acute coronary syndrome in multivessel disease and a study on the long-term effects of an aggressive lipid-lowering protocol in hospitals. It also includes articles on OCT imaging in STEMI patients, outcomes with ultrathin-strut drug-eluting stents, neoatherosclerosis in ACS patients, machine learning to predict post-PCI outcomes, and innovative pacing methods during TAVR.

 

Using physiology in managing ACS with MVD; aggressive lipid-lowering as a hospital protocol; OCT findings in acute STEMI in the young; Ultrathin-strut DES; early in-stent neoatherosclerosis and ACS; hybrid DCB/DES strategy in PCI; machine learning in predicting PCI outcomes; and much more…
Kaul U
Less is more: a new “thin-king” for DES?
Zaman A, Kumar A
AsiaIntervention 2024;10:151-152
In-stent neoatherosclerosis: a new problem or an opportunity to rethink the treatment of coronary disease?
Ussia G, Cocco N
AsiaIntervention 2024;10:153-154
Role of physiology in the management of multivessel disease among patients with acute coronary syndrome
Ganzorig N, Pompei G, Jenkins K, Wang W, Rubino F, Gill K, Kunadian V
AsiaIntervention 2024;10:157-168
A hospital lipid-lowering protocol improves 2-year clinical outcomes in patients with acute coronary syndrome
Nakao S, Ishihara T, Tsujimura T, Iida O, Hata Y, Toyoshima T, Higashino N, Kusuda M, Mano T
AsiaIntervention 2024;10:169-176
OCT-based comparative evaluation of culprit lesion morphology in very young versus older adult patients with STEMI
Girish M, Gupta M, Maehara A, Matsumura M, Bansal A, Kunal S, Batra V, Mohanty A, Qamar A, Mintz G, Ali Z, Yusuf J
AsiaIntervention 2024;10:177-185
Clinical safety and performance of the world’s thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES – 1 study
Kunjukrishnapilla S, Arneja J, Kumar D, Arora P, Thagachagere R, Ganesan M, Davidson D, Roy S, Chandra S, Thakkar A
AsiaIntervention 2024;10:195-202
Impact of acute coronary syndrome on early in-stent neoatherosclerosis as shown by optical coherence tomography
Nakao K, Yamazaki T, Fujisawa N, Kure Y, Yamaguchi T, Kagawa S, Shimada T, Shibata A, Ito A, Otsuka K, Izumiya Y, Fukuda D
AsiaIntervention 2024;10:203-211
Hybrid strategy of drug-eluting stent and drug-coated balloon in the treatment of de novo coronary artery disease: 1-year clinical outcomes
Teo J, Noor T, Ahmad N, Zainal Z, Wong S, Thum C, Aris F, Teh K, Palaniappan G, Koh H, Roslan A, Rusani B, Ganesan K, Hadi H
AsiaIntervention 2024;10:212-218
First-in-human novel pacing-over-the-wire technique during TAVR with the SENTINEL cerebral protection device: the SENTIPACE pilot study
Wong I, Ko A, Chiang M, Shing Fung Chui A, Ka Chun Chan A, Chan K, Lee MK
AsiaIntervention 2024;10:233-235

Latest videos